These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23850203)

  • 1. Molecular design, synthesis and biological evaluation of 1,4-dihydro-4-oxoquinoline ribonucleosides as TcGAPDH inhibitors with trypanocidal activity.
    Soares FA; Sesti-Costa R; da Silva JS; de Souza MC; Ferreira VF; Santos Fda C; Monteiro PA; Leitão A; Montanari CA
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4597-601. PubMed ID: 23850203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, purification and kinetic characterization of His-tagged glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi.
    Cheleski J; Freitas RF; Wiggers HJ; Rocha JR; de Araújo AP; Montanari CA
    Protein Expr Purif; 2011 Apr; 76(2):190-6. PubMed ID: 21138769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of methods in cheminformatics and biocalorimetry for the design of trypanosomatid enzyme inhibitors.
    Prokopczyk IM; Ribeiro JF; Sartori GR; Sesti-Costa R; Silva JS; Freitas RF; Leitão A; Montanari CA
    Future Med Chem; 2014 Jan; 6(1):17-33. PubMed ID: 24358945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiparasitic effect of (-)-α-bisabolol against Trypanosoma cruzi Y strain forms.
    de Menezes RRPPB; Sampaio TL; Lima DB; Sousa PL; de Azevedo IEP; Magalhães EP; Tessarolo LD; Marinho MM; Dos Santos RP; Martins AMC
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114860. PubMed ID: 31353066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.
    Maluf FV; Andricopulo AD; Oliva G; Guido RV
    Future Med Chem; 2013 Nov; 5(17):2019-35. PubMed ID: 24215344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones.
    Ma X; Zhou W; Brun R
    Bioorg Med Chem Lett; 2009 Feb; 19(3):986-9. PubMed ID: 19095449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity.
    Moreira DR; Leite AC; Cardoso MV; Srivastava RM; Hernandes MZ; Rabello MM; da Cruz LF; Ferreira RS; de Simone CA; Meira CS; Guimaraes ET; da Silva AC; dos Santos TA; Pereira VR; Soares MB
    ChemMedChem; 2014 Jan; 9(1):177-88. PubMed ID: 24203393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,2,3-Triazole-based analogue of benznidazole displays remarkable activity against Trypanosoma cruzi.
    de Andrade P; Galo OA; Carvalho MR; Lopes CD; Carneiro ZA; Sesti-Costa R; de Melo EB; Silva JS; Carvalho I
    Bioorg Med Chem; 2015 Nov; 23(21):6815-26. PubMed ID: 26476667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activity of 2,4-diaryl-1,2,3,4-tetrahydroquinolines on Trypanosoma cruzi epimastigotes and amastigotes expressing β-galactosidase.
    Fonseca-Berzal C; Merchán Arenas DR; Romero Bohórquez AR; Escario JA; Kouznetsov VV; Gómez-Barrio A
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4851-6. PubMed ID: 23899616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of new growth inhibitors of Trypanosoma cruzi (epimastigotes).
    Schvartzapel AJ; Zhong L; Docampo R; Rodriguez JB; Gros EG
    J Med Chem; 1997 Jul; 40(15):2314-22. PubMed ID: 9240347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents.
    Ferreira RS; Dessoy MA; Pauli I; Souza ML; Krogh R; Sales AI; Oliva G; Dias LC; Andricopulo AD
    J Med Chem; 2014 Mar; 57(6):2380-92. PubMed ID: 24533839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
    Nogueira Silva JJ; Pavanelli WR; Gutierrez FR; Alves Lima FC; Ferreira da Silva AB; Santana Silva J; Wagner Franco D
    J Med Chem; 2008 Jul; 51(14):4104-14. PubMed ID: 18570370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms.
    Becerra MC; Guiñazú N; Hergert LY; Pellegrini A; Mazzieri MR; Gea S; Albesa I
    Exp Parasitol; 2012 May; 131(1):57-62. PubMed ID: 22425748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents.
    Paula FR; Jorge SD; de Almeida LV; Pasqualoto KF; Tavares LC
    Bioorg Med Chem; 2009 Apr; 17(7):2673-9. PubMed ID: 19303308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of parthenolide and benznidazole on Trypanosoma cruzi.
    Pelizzaro-Rocha KJ; Tiuman TS; Izumi E; Ueda-Nakamura T; Dias Filho BP; Nakamura CV
    Phytomedicine; 2010 Dec; 18(1):36-9. PubMed ID: 21035317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
    Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
    Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease.
    Keenan M; Abbott MJ; Alexander PW; Armstrong T; Best WM; Berven B; Botero A; Chaplin JH; Charman SA; Chatelain E; von Geldern TW; Kerfoot M; Khong A; Nguyen T; McManus JD; Morizzi J; Ryan E; Scandale I; Thompson RA; Wang SZ; White KL
    J Med Chem; 2012 May; 55(9):4189-204. PubMed ID: 22536986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.
    Bressi JC; Verlinde CL; Aronov AM; Shaw ML; Shin SS; Nguyen LN; Suresh S; Buckner FS; Van Voorhis WC; Kuntz ID; Hol WG; Gelb MH
    J Med Chem; 2001 Jun; 44(13):2080-93. PubMed ID: 11405646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi.
    Esteva MI; Kettler K; Maidana C; Fichera L; Ruiz AM; Bontempi EJ; Andersson B; Dahse HM; Haebel P; Ortmann R; Klebe G; Schlitzer M
    J Med Chem; 2005 Nov; 48(23):7186-91. PubMed ID: 16279776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
    Aronov AM; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.